Cargando…
Erratum to: Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079605/ http://dx.doi.org/10.1007/s10120-012-0205-y |
_version_ | 1782323872333299712 |
---|---|
author | Yamaguchi, Kensei Sawaki, Akira Doi, Toshihiko Satoh, Taroh Yamada, Yasuhide Omuro, Yasushi Nishina, Tomohiro Boku, Narikazu Chin, Keisho Hamamoto, Yasuo Takiuchi, Hiroya Komatsu, Yoshito Saji, Shigehira Koizumi, Wasaburo Miyata, Yoshinori Sato, Atsushi Baba, Eishi Tamura, Takao Abe, Takashi Ohtsu, Atsushi |
author_facet | Yamaguchi, Kensei Sawaki, Akira Doi, Toshihiko Satoh, Taroh Yamada, Yasuhide Omuro, Yasushi Nishina, Tomohiro Boku, Narikazu Chin, Keisho Hamamoto, Yasuo Takiuchi, Hiroya Komatsu, Yoshito Saji, Shigehira Koizumi, Wasaburo Miyata, Yoshinori Sato, Atsushi Baba, Eishi Tamura, Takao Abe, Takashi Ohtsu, Atsushi |
author_sort | Yamaguchi, Kensei |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4079605 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Springer Japan |
record_format | MEDLINE/PubMed |
spelling | pubmed-40796052014-07-25 Erratum to: Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study Yamaguchi, Kensei Sawaki, Akira Doi, Toshihiko Satoh, Taroh Yamada, Yasuhide Omuro, Yasushi Nishina, Tomohiro Boku, Narikazu Chin, Keisho Hamamoto, Yasuo Takiuchi, Hiroya Komatsu, Yoshito Saji, Shigehira Koizumi, Wasaburo Miyata, Yoshinori Sato, Atsushi Baba, Eishi Tamura, Takao Abe, Takashi Ohtsu, Atsushi Gastric Cancer Erratum Springer Japan 2012-11-13 2013 /pmc/articles/PMC4079605/ http://dx.doi.org/10.1007/s10120-012-0205-y Text en © The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2012 |
spellingShingle | Erratum Yamaguchi, Kensei Sawaki, Akira Doi, Toshihiko Satoh, Taroh Yamada, Yasuhide Omuro, Yasushi Nishina, Tomohiro Boku, Narikazu Chin, Keisho Hamamoto, Yasuo Takiuchi, Hiroya Komatsu, Yoshito Saji, Shigehira Koizumi, Wasaburo Miyata, Yoshinori Sato, Atsushi Baba, Eishi Tamura, Takao Abe, Takashi Ohtsu, Atsushi Erratum to: Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study |
title | Erratum to: Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study |
title_full | Erratum to: Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study |
title_fullStr | Erratum to: Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study |
title_full_unstemmed | Erratum to: Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study |
title_short | Erratum to: Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study |
title_sort | erratum to: efficacy and safety of capecitabine plus cisplatin in japanese patients with advanced or metastatic gastric cancer: subset analyses of the avagast study and the toga study |
topic | Erratum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079605/ http://dx.doi.org/10.1007/s10120-012-0205-y |
work_keys_str_mv | AT yamaguchikensei erratumtoefficacyandsafetyofcapecitabinepluscisplatininjapanesepatientswithadvancedormetastaticgastriccancersubsetanalysesoftheavagaststudyandthetogastudy AT sawakiakira erratumtoefficacyandsafetyofcapecitabinepluscisplatininjapanesepatientswithadvancedormetastaticgastriccancersubsetanalysesoftheavagaststudyandthetogastudy AT doitoshihiko erratumtoefficacyandsafetyofcapecitabinepluscisplatininjapanesepatientswithadvancedormetastaticgastriccancersubsetanalysesoftheavagaststudyandthetogastudy AT satohtaroh erratumtoefficacyandsafetyofcapecitabinepluscisplatininjapanesepatientswithadvancedormetastaticgastriccancersubsetanalysesoftheavagaststudyandthetogastudy AT yamadayasuhide erratumtoefficacyandsafetyofcapecitabinepluscisplatininjapanesepatientswithadvancedormetastaticgastriccancersubsetanalysesoftheavagaststudyandthetogastudy AT omuroyasushi erratumtoefficacyandsafetyofcapecitabinepluscisplatininjapanesepatientswithadvancedormetastaticgastriccancersubsetanalysesoftheavagaststudyandthetogastudy AT nishinatomohiro erratumtoefficacyandsafetyofcapecitabinepluscisplatininjapanesepatientswithadvancedormetastaticgastriccancersubsetanalysesoftheavagaststudyandthetogastudy AT bokunarikazu erratumtoefficacyandsafetyofcapecitabinepluscisplatininjapanesepatientswithadvancedormetastaticgastriccancersubsetanalysesoftheavagaststudyandthetogastudy AT chinkeisho erratumtoefficacyandsafetyofcapecitabinepluscisplatininjapanesepatientswithadvancedormetastaticgastriccancersubsetanalysesoftheavagaststudyandthetogastudy AT hamamotoyasuo erratumtoefficacyandsafetyofcapecitabinepluscisplatininjapanesepatientswithadvancedormetastaticgastriccancersubsetanalysesoftheavagaststudyandthetogastudy AT takiuchihiroya erratumtoefficacyandsafetyofcapecitabinepluscisplatininjapanesepatientswithadvancedormetastaticgastriccancersubsetanalysesoftheavagaststudyandthetogastudy AT komatsuyoshito erratumtoefficacyandsafetyofcapecitabinepluscisplatininjapanesepatientswithadvancedormetastaticgastriccancersubsetanalysesoftheavagaststudyandthetogastudy AT sajishigehira erratumtoefficacyandsafetyofcapecitabinepluscisplatininjapanesepatientswithadvancedormetastaticgastriccancersubsetanalysesoftheavagaststudyandthetogastudy AT koizumiwasaburo erratumtoefficacyandsafetyofcapecitabinepluscisplatininjapanesepatientswithadvancedormetastaticgastriccancersubsetanalysesoftheavagaststudyandthetogastudy AT miyatayoshinori erratumtoefficacyandsafetyofcapecitabinepluscisplatininjapanesepatientswithadvancedormetastaticgastriccancersubsetanalysesoftheavagaststudyandthetogastudy AT satoatsushi erratumtoefficacyandsafetyofcapecitabinepluscisplatininjapanesepatientswithadvancedormetastaticgastriccancersubsetanalysesoftheavagaststudyandthetogastudy AT babaeishi erratumtoefficacyandsafetyofcapecitabinepluscisplatininjapanesepatientswithadvancedormetastaticgastriccancersubsetanalysesoftheavagaststudyandthetogastudy AT tamuratakao erratumtoefficacyandsafetyofcapecitabinepluscisplatininjapanesepatientswithadvancedormetastaticgastriccancersubsetanalysesoftheavagaststudyandthetogastudy AT abetakashi erratumtoefficacyandsafetyofcapecitabinepluscisplatininjapanesepatientswithadvancedormetastaticgastriccancersubsetanalysesoftheavagaststudyandthetogastudy AT ohtsuatsushi erratumtoefficacyandsafetyofcapecitabinepluscisplatininjapanesepatientswithadvancedormetastaticgastriccancersubsetanalysesoftheavagaststudyandthetogastudy |